Ask Questions (ASQ):Implementation of a Communication Intervention
Public ClinicalTrials.gov record NCT05025748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Ask Questions (ASQ): Implementation of a Communication Intervention to Improve Patient-Oncologist Communication in the Outpatient Medical Oncology Setting
Study identification
- NCT ID
- NCT05025748
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Other
- Enrollment
- 81 participants
Conditions and interventions
Conditions
- Stage II Bladder Cancer
- Stage II Breast Cancer
- Stage II Cervical Cancer
- Stage II Colorectal Cancer
- Stage II Kidney Cancer
- Stage II Lung Cancer
- Stage II Ovarian Cancer
- Stage II Prostate Cancer
- Stage III Bladder Cancer
- Stage III Breast Cancer
- Stage III Cervical Cancer
- Stage III Colorectal Cancer
- Stage III Kidney Cancer
- Stage III Lung Cancer
- Stage III Ovarian Cancer
- Stage III Prostate Cancer
- Stage IV Bladder Cancer
- Stage IV Breast Cancer
- Stage IV Colorectal Cancer
- Stage IV Kidney Cancer
- Stage IV Lung Cancer
- Stage IV Ovarian Cancer
- Stage IV Prostate Cancer
Interventions
- Behavioral Intervention Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 24, 2021
- Primary completion
- Aug 30, 2022
- Completion
- Aug 30, 2022
- Last update posted
- Aug 15, 2023
2021 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 1
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Karmanos Cancer Institute at McLaren Bay Region | Bay City | Michigan | 48706 | — |
| Karmanos Cancer Institute at McLaren Clarkston | Clarkston | Michigan | 48346 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Karmanos Cancer Institute at McLaren Flint | Flint | Michigan | 48532 | — |
| Karmanos Cancer Institute at McLaren Macomb | Mount Clemens | Michigan | 48043 | — |
| Karmanos Cancer Institute at McLaren Central Michigan | Mount Pleasant | Michigan | 48858 | — |
| Karmanos Cancer Institute at McLaren Northern Michigan | Petoskey | Michigan | 49770 | — |
| Karmanos Cancer Institute at McLaren Port Huron | Port Huron | Michigan | 48060 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05025748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2023 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05025748 live on ClinicalTrials.gov.